{"id":"https://openalex.org/W2097170334","doi":"https://doi.org/10.1080/01926230500214657","title":"Generalized Cellular Hypertrophy is Induced by a Dual-Acting PPAR Agonist in Rat Urinary Bladder Urothelium In Vivo","display_name":"Generalized Cellular Hypertrophy is Induced by a Dual-Acting PPAR Agonist in Rat Urinary Bladder Urothelium In Vivo","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-01","ids":{"openalex":"https://openalex.org/W2097170334","doi":"https://doi.org/10.1080/01926230500214657","mag":"2097170334","pmid":"https://pubmed.ncbi.nlm.nih.gov/16076770"},"language":"en","primary_location":{"id":"doi:10.1080/01926230500214657","doi":"https://doi.org/10.1080/01926230500214657","is_oa":false,"landing_page_url":"https://doi.org/10.1080/01926230500214657","pdf_url":null,"source":{"id":"https://openalex.org/S145558524","display_name":"Toxicologic Pathology","issn_l":"0192-6233","issn":["0192-6233","1533-1601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicologic Pathology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2097170334"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036843897","display_name":"Martin B. Oleksiewicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin B. Oleksiewicz","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","Novo Nordisk A/S, Novo Nordisk Park, Department of Virology and Molecular Toxicology, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]},{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Department of Virology and Molecular Toxicology, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051655702","display_name":"Inger Thorup","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Inger Thorup","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Henriette S. Nielsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henriette S. Nielsen","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021082779","display_name":"Hanne V. Andersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hanne V. Andersen","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018185847","display_name":"Anne Charlotte Hegelund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Charlotte Hegelund","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lars Iversen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Iversen","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078628576","display_name":"Torben S. Guldberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Torben S. Guldberg","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042713924","display_name":"Peter R. Brinck","orcid":"https://orcid.org/0000-0002-4637-3238","observed_orcids":["https://orcid.org/0000-0002-4637-3238"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter R. Brinck","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089555429","display_name":"Ingrid Sj\u00f6gren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid Sjogren","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078510643","display_name":"Ulla K. Thinggaard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ulla K. Thinggaard","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015177645","display_name":"L. Nellemann J\u00f8rgensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lis J\u00f8rgensen","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030369642","display_name":"Marianne B. Jensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marianne B. Jensen","raw_affiliation_strings":["Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Novo Nordisk Park, Maalov, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I189090001"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.5666,"has_fulltext":false,"cited_by_count":46,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8017395,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"33","issue":"5","first_page":"552","last_page":"560"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.10329999774694443,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pparalpha-gamma-dual-agonist","display_name":"PPAR\u03b1/\u03b3 dual agonist","score":0.6769999861717224},{"id":"https://openalex.org/keywords/bladder-carcinogenesis","display_name":"bladder carcinogenesis","score":0.699999988079071},{"id":"https://openalex.org/keywords/cell-cycle-distribution","display_name":"cell cycle distribution","score":0.6129999756813049},{"id":"https://openalex.org/keywords/g2-m-phase","display_name":"G2/M phase","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cell-size","display_name":"cell size","score":0.3569999933242798},{"id":"https://openalex.org/keywords/protein-content","display_name":"protein content","score":0.6380000114440918},{"id":"https://openalex.org/keywords/flow-cytometry","display_name":"flow cytometry","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2777540882","wikidata":"https://www.wikidata.org/wiki/Q11878994","display_name":"Urothelium","level":3,"score":0.9480075240135193},{"id":"https://openalex.org/C2779762690","wikidata":"https://www.wikidata.org/wiki/Q9382","display_name":"Urinary bladder","level":2,"score":0.6186256408691406},{"id":"https://openalex.org/C2910041100","wikidata":"https://www.wikidata.org/wiki/Q11878994","display_name":"Urothelial Cell","level":4,"score":0.6001437306404114},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.5236375331878662},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4895087480545044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4442235827445984},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4440736174583435},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43411147594451904},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32587873935699463},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3085952401161194},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006984","descriptor_name":"Hypertrophy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008856","descriptor_name":"Microscopy, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011506","descriptor_name":"Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016650","descriptor_name":"Fluorescein-5-isothiocyanate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019459","descriptor_name":"Urothelium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/01926230500214657","doi":"https://doi.org/10.1080/01926230500214657","is_oa":false,"landing_page_url":"https://doi.org/10.1080/01926230500214657","pdf_url":null,"source":{"id":"https://openalex.org/S145558524","display_name":"Toxicologic Pathology","issn_l":"0192-6233","issn":["0192-6233","1533-1601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicologic Pathology","raw_type":"journal-article"},{"id":"pmid:16076770","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16076770","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicologic pathology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W49815108","https://openalex.org/W1584652055","https://openalex.org/W1647126819","https://openalex.org/W1652234506","https://openalex.org/W1812285428","https://openalex.org/W1972453909","https://openalex.org/W1978125779","https://openalex.org/W1979612739","https://openalex.org/W1984736455","https://openalex.org/W2000239559","https://openalex.org/W2034577350","https://openalex.org/W2035003468","https://openalex.org/W2037911653","https://openalex.org/W2044467623","https://openalex.org/W2054154194","https://openalex.org/W2060752803","https://openalex.org/W2064560407","https://openalex.org/W2064921473","https://openalex.org/W2065756002","https://openalex.org/W2066514161","https://openalex.org/W2074946370","https://openalex.org/W2092108654","https://openalex.org/W2092621119","https://openalex.org/W2092982893","https://openalex.org/W2099767283","https://openalex.org/W2099847590","https://openalex.org/W2126747820","https://openalex.org/W2136711907","https://openalex.org/W2147326561","https://openalex.org/W2232458214","https://openalex.org/W2293248093","https://openalex.org/W2406766584","https://openalex.org/W2416938211","https://openalex.org/W2419337843"],"related_works":["https://openalex.org/W2150985748","https://openalex.org/W2059083569","https://openalex.org/W2156994876","https://openalex.org/W2156721436","https://openalex.org/W2166366523","https://openalex.org/W1971363958","https://openalex.org/W2034706025","https://openalex.org/W2099929207"],"abstract_inverted_index":{"Some":[0],"developmental":[1],"dual-acting":[2],"PPARalpha/gamma":[3],"agonists,":[4],"such":[5],"as":[6],"ragaglitazar,":[7,36],"have":[8],"shown":[9],"carcinogenic":[10],"effects":[11],"in":[12,27,52,56,60,78,85,103,135,168,175,205],"the":[13,28,79,86,136,155,169,184,209],"rodent":[14],"urinary":[15],"bladder":[16,29,62,107,157],"urothelium":[17,30,89,137],"after":[18],"months-years":[19],"of":[20,31,47,75,106,122,138,171,187,192,212],"dosing.":[21],"We":[22],"examined":[23],"early":[24,151,202],"(precancerous)":[25],"changes":[26,100,174],"rats":[32,114],"orally":[33],"dosed":[34],"with":[35,125],"using":[37],"a":[38,57,119,188,193,200],"newly":[39],"developed":[40],"flow":[41,67],"cytometric":[42],"method.":[43],"Following":[44],"3":[45],"weeks":[46],"oral":[48],"ragaglitazar":[49],"dosing,":[50],"increases":[51],"physical":[53],"size":[54,143],"occurred":[55,167],"generalized":[58],"fashion":[59],"rat":[61],"urothelial":[63,76,95,110,158,162],"cells,":[64],"determined":[65],"by":[66,90],"cytometry.":[68],"Protein/DNA":[69],"measurements":[70],"confirmed":[71],"increased":[72],"protein":[73,145],"content":[74,146],"cells":[77,111],"bladder,":[80],"and":[81,144],"hypertrophy":[82,141,163,197],"was":[83,149,164],"observed":[84],"kidney":[87],"pelvis":[88],"histopathology.":[91],"In":[92,129],"animals":[93],"exhibiting":[94],"hypertrophy,":[96],"no":[97],"cell":[98,159,176],"cycle":[99,177],"were":[101,115],"detected":[102],"parallel":[104],"samples":[105],"urothelium.":[108],"Interestingly,":[109],"from":[112],"normal":[113],"found":[116],"to":[117],"constitute":[118],"unique":[120],"type":[121],"noncycling":[123],"population,":[124],"high":[126],"G2/M":[127],"fractions.":[128],"summary,":[130],"our":[131,180],"findings":[132],"showed":[133],"that":[134,153],"ragaglitazar-treated":[139],"animals,":[140],"(increased":[142],"per":[147],"cell)":[148],"an":[150],"change,":[152],"affected":[154],"whole":[156],"population.":[160],"The":[161],"primary,":[165],"i.e.,":[166],"absence":[170],"similarly":[172],"pronounced":[173],"distributions.":[178],"To":[179],"knowledge,":[181],"this":[182],"is":[183],"first":[185],"report":[186],"direct":[189],"hypertrophic":[190],"effect":[191,211],"PPAR":[194,213],"agonist.":[195],"Urothelial":[196],"might":[198],"be":[199],"relevant":[201],"biological":[203],"endpoint":[204],"mechanistic":[206],"studies":[207],"regarding":[208],"bladder-carcinogenic":[210],"agonists.":[214]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2097170334","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
